We use UALCAN (http://ualcan.path.uab.edu/index.html) to analyze Clinical Proteomic Tumor Analysis Consortium (CPTAC) data and find that YB-1 is upregulated in various molecular subtypes of breast cancer (Fig. 4d). This evidence concerns the gene YBX1 and neoplasm.